Beijer Alma AB Series B (0YG7)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 313.50 |
|---|---|
| 52-week range | 218.48 – 314.50 |
| Return, 1 month / 3 months | +5.2% / +8.7% |
| Return, 1 year / 3 years | +27.3% / +88.3% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 27.9% |
| Worst drawdown (1 year) | -23.4% |
| Average daily value traded | 0.46M SEK |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Beijer Alma is a Swedish industrial group that owns businesses making components for industrial customers. Its Lesjöfors unit produces springs, wire and strip components, while Habia Cable supplies cables and cable systems for demanding applications. The group serves manufacturers and industrial buyers in Europe and other markets from its base in Sweden, and its operating companies focus on engineered metal and cable products for machinery, vehicles and other equipment.
On this site Beijer Alma AB Series B appears as a stock on the London Exchange (UK), code 0YG7, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Beijer Alma AB Series B (0YG7) trades on the London Exchange in UK. It last closed at SEK 313.50 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 828 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.3% and over the last three months it rose 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.1% | ||
| From 52-week high | 0.0% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.7% | ||
| 6-month return | 15.0% | ||
| 12-month return, skipping the last month | 21.0% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.4% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.46M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | +5.2% |
| 3 months | +8.7% |
| 6 months | +15.0% |
| 1 year | +27.3% |
| 3 years | +88.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 301.45 / 282.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2026 | SEK 2.0000 |
| 7 May 2025 | SEK 3.9500 |
| 8 May 2024 | SEK 3.8500 |
| 31 Mar 2023 | SEK 3.7500 |
| 31 Mar 2022 | SEK 3.5000 |
| 24 Mar 2021 | SEK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.